Jeremy Wu

Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice

Raffaella Rossin, Ron M. Versteegen, Jeremy Wu et al. · Nature Communications · 2018 · 277 citations · Full text

Pharmacy, Oncology, Pharmacology +17

H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

Jaya Julie Joshi, Heather Coffey, Erik Corcoran et al. · Cancer Research · 2017 · 151 citations

Medicine, Oncology, Pharmacology +15

Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion

Lee A. Albacker, Jeremy Wu, Peter Smith et al. · PLoS ONE · 2017 · 137 citations · Full text

Medicine, Genetics, Oncology +17

Bioorthogonal Tetrazine Carbamate Cleavage by Highly Reactive <i>trans</i> -Cyclooctene

Arthur H. A. M. van Onzen, Ron M. Versteegen, Freek J. M. Hoeben et al. · Journal of the American Chemical Society · 2020 · 118 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +14

An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of <i>CASQ2</i> -Catecholaminergic Polymorphic Ventricular Tachycardia

Kevin Ng, Erron W. Titus, Krystien V.V. Lieve et al. · Circulation · 2020 · 83 citations · Full text

Medicine, Cardiology, Genetics +16